Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
AIM ImmunoTech's CEO, Thomas K. Equels, published an article emphasizing the importance of integrating broad-spectrum antiviral countermeasures like Ampligen® into military biodefense strategies. The article highlights preclinical research demonstrating Ampligen's potential efficacy against Ebola and SARS-related viruses, advocating for early gover…
Adamas Trust, Inc., a US-listed REIT on Nasdaq (ticker: ADAM), announced the pricing of a $90 million public offering of 9.6% senior notes due in 2031, with a 30-day overallotment option of up to $13.5 million. The company plans to use proceeds for general corporate needs including acquiring targeted assets and repaying debt. The notes will be seni…
RoboStrategy, Inc., a Nasdaq-listed closed-end fund focused on robotics and physical AI private companies, announced a NAV per share increase to $11.32 as of July 31, 2026, marking a 10.33% rise from June 30, 2026. The fund holds equity in innovators like Figure AI, Apptronik, and Dyna Robotics, reflecting robust growth and investor confidence in t…
Information Services Group (III) is a compact, profitable sourcing and technology advisory firm trading at roughly $5.12. The business generates meaningful free cash flow ($16.95M), carries modest leverage (debt/equity ~0.62), and pays a quarterly cash dividend. With EV of ~$285M and EV/EBITDA ~11.4, the stock looks reasonable for a 180-day trade t…
ENvue Medical, a US-based medical technology firm specializing in enteral care solutions, announced an equity financing facility of up to $50 million with an institutional investor. The funding aims to enhance the company's financial flexibility to support commercial expansion, accelerate adoption of its feeding tube navigation system, advance next…
Beeline Holdings, a technology-driven mortgage lender, announced that CEO Nicholas Liuzza invested $500,000 via a convertible note, reflecting confidence in the company’s strategy and recent progress. The note will convert into shares at a price not below $1.50 or the market VWAP, aligning leadership interests with shareholders. The company is purs…
Fluent (FLNT) is trading at roughly $4.12 with a market cap near $145M and an enterprise value to sales of ~0.75x. The company is shifting toward higher-margin commerce media (up 121% in Q2 2025) while adding New York retail and cultivation via the RIV Capital deal. For traders, the set-up is a mid-term long: entry $4.12, stop $3.25, target $6.00 o…
Flux Power Holdings, Inc., a NASDAQ-listed company specializing in advanced lithium-ion energy storage solutions and fleet intelligence technology, will report its fiscal fourth quarter and full year 2026 financial results on August 20, 2026, after market close, followed by a conference call led by CEO Krishna Vanka and CFO Kevin Royal.
VEON's Bangladesh subsidiary, Banglalink, has received a Payment Service Provider license from Bangladesh Bank to launch Mukto Pay, a digital payment platform targeting a September 2026 commercial launch. This move supports VEON's broader investment plans in Bangladesh, aiming to enhance digital financial services and infrastructure. Digital financ…
Alphabet looks underpriced relative to the durability of its AI-driven revenue streams. With a market cap near $4.2 trillion, free cash flow of roughly $53.3B and a P/E around 17x, the stock offers an asymmetric risk/reward as hyperscaler demand for AI infrastructure remains structural. I recommend a long trade sized with a medium-risk allocation, …
SpaceX faces intense skepticism today, but the company's differentiated launch economics, Starlink revenue runway and Starship-enabled TAM expansion argue for a patient, defined-risk long. This trade idea lays out an entry at $85.00, a stop at $66.00 and a $140.00 target over a long-term (180 trading days) horizon.
Odysight.ai Inc., an AI-driven predictive maintenance solutions provider for defense and industrial sectors, announced its management team's participation in key investor conferences during Q3 2026, including the Sidoti Virtual Micro-Cap Conference and the H.C. Wainwright 28th Annual Global Investment Conference, to showcase its technology and enga…
PN Smart Energy Limited (NASDAQ: PN) announced that its subsidiary, Nanjing Cesun Power Development, has signed a framework agreement to acquire six rooftop solar projects totaling 9.9 MW in Ningbo, Zhejiang Province from Zhejiang Yuntan Technology. The acquisition, valued at approximately $4.45 million, is a key step in PN Smart's strategic transi…
Founder Group Limited has signed a RM5.58 million (US$1.37 million) contract to build a 1.78 MW rooftop solar system for a shrimp farming and processing facility in Kedah, Malaysia. This marks the company's second major aquaculture-focused renewable energy project, supporting Malaysia's growing aquaculture sector and national renewable energy goals…
Aprea Therapeutics reported Q2 2026 financial results and provided updates on its clinical-stage oncology programs. Enrollment in the Phase 1 ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating with expansion to more clinical sites. Early data show promising anti-tumor activity and manageable tolerability. The company plans to advance…
Exyn Technologies announced the formation of a Defense Advisory Board to enhance its efforts in securing and scaling autonomous technology programs with the U.S. and allied defense sectors. Andrew Knaggs, a former Deputy Assistant Secretary of Defense and decorated Green Beret, has been named the inaugural member. This move supports Exyn's recent g…
Propanc Biopharma highlights its lead candidate PRP, a novel proenzyme therapy aiming to treat aggressive, treatment-resistant RAS-driven cancers by promoting cancer cell differentiation and reversing metastatic processes. PRP differs from current RAS inhibitors by targeting cancer stem cells and epithelial-mesenchymal transition rather than solely…
Cloudastructure, Inc., a NASDAQ-listed AI surveillance and security analytics company, has been awarded the installation contract for a third multifamily property with a longtime Baltimore developer. The initial phase includes installing approximately 70 cameras, with advanced AI surveillance and remote guarding services expected to be utilized aft…
Dyadic International, Inc. reported its Q2 2026 financial results showing continued commercialization progress across recombinant proteins and strategic OEM partnerships. The company advanced multiple product shipments, scale-up agreements, and global health initiatives using its proprietary C1 biomanufacturing platform. Despite increased costs and…
Powerus, through its subsidiary Tandem Defense, received a $2.51 million purchase order from a Department of War prime contractor for 1,500 U.S.-made FPV drones, pilot kits, and spare parts. The drones are manufactured domestically, compliant with NDAA and TAA, and delivery is expected within 60 days. The announcement coincides with Aureus Greenway…
Alico, Inc., a Florida-based agribusiness and land management company, announced that its CEO will present at the 17th Annual Midwest IDEAS Investor Conference. The presentation will highlight Alico's strategic transformation and diversified land operations across 47,300 acres in Florida following its 2025 restructuring. The company aims to leverag…
Bath & Body Works, Inc. (NYSE: BBWI) announced that it will report its financial results for the second quarter of 2026 before the market opens on August 26, 2026. The company will also host a conference call featuring CEO Daniel Heaf and interim CFO Tom Javitch to discuss the results and provide a business update. Supplemental materials will be av…
CLEAR (YOU) has pulled back from recent highs into oversold territory while fundamentals - membership growth, revenue beats and rising free cash flow - remain intact. This trade idea proposes a disciplined buy-the-dip entry at $46.50 with a $60 target over a swing window as travel demand and identity-verification adoption continue to accelerate.
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, announced that the Japanese Patent Office has granted a patent covering NeuroThera's proprietary pharmacological combination involving 4-aminophenol derivatives and N-acylethanolamines. The patent protects formulations aimed at enhancing the analgesic and antipyretic effects of 4…
Openlane's stock slid 5.3% in pre-market trading following the announcement that Ignition Acquisition Holdings LP, a fund advised by Apax Partners, is selling 8,000,000 shares in an underwritten secondary offering. The shares were converted from Series A Convertible Preferred Stock in May 2026. Openlane will not receive proceeds from the sale and h…
